Glaukos First-Quarter 2024 Financial Performance Overview

TipRanks04:24

Glaukos Sees FY24 Net Sales $357M-$365M Vs $356.669M Est.

Glaukos Sees FY24 Net Sales $357M-$365M Vs $356.669M Est.

Benzinga04:20

Earnings Flash (GKOS) GLAUKOS CORPORATION Reports Q1 Revenue $85.6M, Vs. Street Est of $79.7M

04:13 PM EDT, 05/01/2024 (MT Newswires) -- Earnings Flash (GKOS) GLAUKOS CORPORATION Reports Q1 Revenue $85.6M, vs. Street Est of $79.7M

MT Newswires04:13

Glaukos Q1 2024 Adj EPS $(0.70) Misses $(0.57) Estimate, Sales $85.600M Beat $79.600M Estimate

Glaukos (NYSE:GKOS) reported quarterly losses of $(0.70) per share which missed the analyst consensus estimate of $(0.57) by 22.81 percent. The company reported quarterly sales of $85.600 million whi

Benzinga04:07

Press Release: Glaukos Announces First Quarter 2024 Financial Results

Glaukos Announces First Quarter 2024 Financial Results ALISO VIEJO, Calif.--(BUSINESS WIRE)--May 01, 2024-- Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology comp

Dow Jones04:07

Glaukos 1Q Loss/Shr 82c >GKOS

Glaukos 1Q Loss/Shr 82c >GKOS

Dow Jones04:05